comparemela.com

Cogent Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Analyzing TransCode Therapeutics (NASDAQ:RNAZ) & Cogent Biosciences (NASDAQ:COGT)

Analyzing TransCode Therapeutics (NASDAQ:RNAZ) & Cogent Biosciences (NASDAQ:COGT)
modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.

Leerink Partnrs Equities Analysts Raise Earnings Estimates for Cogent Biosciences, Inc (NASDAQ:COGT)

Cogent Biosciences, Inc. (NASDAQ:COGT – Free Report) – Equities researchers at Leerink Partnrs increased their FY2024 earnings estimates for Cogent Biosciences in a note issued to investors on Monday, February 26th. Leerink Partnrs analyst A. Berens now anticipates that the technology company will post earnings per share of ($2.16) for the year, up from their […]

After losing 15% in the past year, Cogent Biosciences, Inc (NASDAQ:COGT) institutional owners must be relieved by the recent gain

Key Insights Given the large stake in the stock by institutions, Cogent Biosciences' stock price might be vulnerable to.

Contrasting Innoviva (NASDAQ:INVA) and Cogent Biosciences (NASDAQ:COGT)

Innoviva (NASDAQ:INVA – Get Rating) and Cogent Biosciences (NASDAQ:COGT – Get Rating) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, earnings, dividends, profitability, analyst recommendations, valuation and risk. Analyst Ratings This is a summary of current recommendations for […]

Cogent Biosciences, Inc Forecasted to Post Q2 2023 Earnings of ($0 56) Per Share (NASDAQ:COGT)

Cogent Biosciences, Inc. (NASDAQ:COGT – Get Rating) – HC Wainwright raised their Q2 2023 earnings estimates for shares of Cogent Biosciences in a report issued on Thursday, June 8th. HC Wainwright analyst R. Burns now anticipates that the technology company will earn ($0.56) per share for the quarter, up from their prior forecast of ($0.67). […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.